Doctor profile · Federal record
Dr. Allyson Kopel, M.D.
Dermatology Physician (CMS: Dermatology) · Sugar Land, TX
- NPI 1174569420
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1327 Lake Pointe Pkwy Ste 416
Sugar Land, TX 774783499
(281) 494-0050
fax (281) 494-0075
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- August 19, 2025
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #M3617
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174569420. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,523
Distinct HCPCS
10
Medicare allowed
$88,548
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 527 | 92 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 334 | 244 | $91 | |
17000 |
Destruction of precancer skin growth, 1 growth | 178 | 126 | $47 | |
11102 |
Biopsy of related skin growth, first growth | 175 | 143 | $96 | |
11103 |
Biopsy of related skin growth, each additional growth | 94 | 51 | $51 | |
17110 |
Destruction of skin growth, 1-14 growths | 53 | 43 | $113 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 53 | 53 | $114 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 43 | 39 | $57 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 23 | 20 | $130 | |
17261 |
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 19 | 15 | $140 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 187. This provider delivers 8.1× the peer median.Open Payments
Industry payments received
All-time total
$1,596
Transactions
77
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 22 | $438.75 | |
| GENZYME CORPORATION | 8 | $226.08 | |
| Regeneron Healthcare Solutions, Inc. | 6 | $179.87 | |
| Amgen Inc. | 11 | $168.00 | |
| Janssen Biotech, Inc. | 11 | $158.40 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $105.11 | |
| Novartis Pharmaceuticals Corporation | 3 | $64.03 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $54.80 | |
| Incyte Corporation | 2 | $40.92 | |
| Galderma Laboratories, L.P. | 2 | $37.49 | |
| Arcutis Biotherapeutics, Inc. | 1 | $25.37 | |
| Almirall LLC | 1 | $23.81 | |
| Lilly USA, LLC | 1 | $20.79 | |
| PFIZER INC. | 1 | $19.17 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $18.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
199
Patients
85
Total drug cost
$8,751
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 35 | 15 | $683 |
| Triamcinolone Acetonide | Generic | 27 | 22 | $166 |
| Doxycycline Monohydrate | Generic | 25 | 0 | $983 |
| Metronidazole | Generic | 24 | 12 | $3,419 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 22 | 11 | $1,245 |
| Clobetasol Propionate | Generic | 21 | 13 | $1,281 |
| Mupirocin | Generic | 17 | 12 | $147 |
| Clindamycin Phosphate | Generic | 16 | 0 | $593 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 12 | 0 | $234 |
Frequently asked questions
What is Dr. Allyson Kopel's medical specialty?
Dr. Allyson Kopel practices Dermatology Physician in Sugar Land, TX.
Where does Dr. Allyson Kopel practice?
Dr. Allyson Kopel practices at 1327 Lake Pointe Pkwy Ste 416, Sugar Land, TX 774783499. Office phone: 2814940050.
What is Dr. Allyson Kopel's NPI?
Dr. Allyson Kopel's National Provider Identifier (NPI) is 1174569420, issued by NPPES.
Does Dr. Allyson Kopel accept Medicare assignment?
Yes. Dr. Allyson Kopel accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Allyson Kopel commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.